VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
IMUX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
IMUXImmunic, Inc.
$15.36$152M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksIMUXQuarterly Financials

Immunic, Inc. (IMUX) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Immunic, Inc. (IMUX) quarterly income statement — complete revenue, gross profit & net income history

IMUX Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold33K000035K031K26K23K0000000000
COGS % of Revenue--------------------
Gross Profit-33K0000-35K0-31K-26K-23K0000000000
Gross Margin %--------------------
Gross Profit Growth %-100%-100%100%-52.17%--------------
Operating Expenses33.2M23.33M25.99M27.08M26.82M25.6M25.73M22.78M23.86M23.36M23.57M25.02M27.25M57.33M20.12M20.61M21.43M21.72M18.39M19.17M
OpEx % of Revenue--------------------
Selling, General & Admin7.58M4.26M5.98M5.71M5.29M3.98M4.36M4.46M5.12M4.1M3.77M3.85M4.29M3.62M3.58M4.07M3.99M3.34M2.91M3.43M
SG&A % of Revenue--------------------
Research & Development25.63M19.07M20.01M21.37M21.53M21.62M21.37M18.32M18.74M19.28M19.8M21.17M22.96M20.73M16.54M16.54M17.45M18.38M15.48M15.74M
R&D % of Revenue--------------------
Other Operating Expenses000000000-23K0001000K000000
Operating Income-33.23M-23.33M-25.99M-27.08M-26.82M-25.63M-25.73M-22.81M-23.88M-23.38M-23.57M-25.02M-27.25M-57.33M-20.12M-20.61M-21.43M-21.72M-18.39M-19.17M
Operating Margin %--------------------
Operating Income Growth %-23.9%8.99%-1.04%-18.71%-12.33%-9.62%-9.15%8.82%12.37%59.21%-17.17%-21.4%-27.13%-163.92%-9.4%-7.51%33.82%-53.07%-35.75%-56.85%
EBITDA-33.2M-23.29M-25.95M-27.04M-26.78M-25.6M-25.68M-22.78M-23.86M-23.36M-23.54M-25M-27.22M-57.31M-20.1M-20.59M-21.41M-21.68M-18.37M-19.16M
EBITDA Margin %--------------------
EBITDA Growth %-23.97%9.03%-1.05%-18.68%-12.27%-9.58%-9.13%8.86%12.36%59.24%-17.1%-21.41%-27.11%-164.32%-9.41%-7.49%33.85%-52.9%-36.06%-56.8%
D&A (Non-Cash Add-back)33K42K40K43K43K35K42K31K26K23K34K22K32K19K17K20K21K40K16K15K
EBIT-33.23M-23.33M-25.99M-27.08M-26.82M-25.18M-25.73M-22.81M-23.88M-23.38M-23.57M-25.02M-27.25M-24.36M-20.12M-20.61M-21.43M-21.72M-18.39M-19.17M
Net Interest Income760K197K419K241K183K429K776K998K1.19M541K766K968K800K698K230K106K7K15K10K13K
Interest Income760K197K419K241K183K429K776K998K1.19M541K766K968K800K698K230K106K7K15K10K13K
Interest Expense00000000000000000000
Other Income/Expense647K4.03M414K263K1.35M456K1.36M1.43M-5.7M1.81M801K1.02M1.98M853K-1.11M-1.29M627K536K-905K1.24M
Pretax Income-32.59M-19.3M-25.58M-26.82M-25.47M-25.18M-24.37M-21.38M-29.58M-21.57M-22.77M-24M-25.27M-56.47M-21.22M-21.9M-20.81M-21.18M-19.29M-17.93M
Pretax Margin %--------------------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-32.59M-19.3M-25.58M-26.82M-25.47M-25.18M-24.37M-21.38M-29.58M-21.57M-22.77M-24M-25.27M-56.47M-21.22M-21.9M-20.81M-21.18M-19.29M-17.93M
Net Margin %--------------------
Net Income Growth %-27.93%23.34%-4.97%-25.44%13.9%-16.7%-7.02%10.91%-17.06%61.8%-7.28%-9.58%-21.45%-166.58%-10.01%-22.12%39.75%-89.85%-49.4%-56.52%
Net Income (Continuing)-32.59M-19.3M-25.58M-26.82M-25.47M-25.18M-24.37M-21.38M-29.58M-21.57M-22.77M-24M-25.27M-56.47M-21.22M-21.9M-20.81M-21.18M-19.29M-17.93M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-1.08-1.60-1.30-2.00-2.50-2.80-2.40-2.10-3.00-4.80-5.10-5.40-5.30-27.80-7.30-7.20-7.20-8.40-7.60-8.20
EPS Growth %56.8%42.86%45.83%4.76%16.67%41.67%52.94%61.11%43.4%82.73%30.14%25%26.39%-230.95%3.95%12.2%55.83%-58.49%-8.57%8.89%
EPS (Basic)-1.08-1.60-1.30-2.00-2.50-2.80-2.40-2.10-3.00-4.80-5.10-5.40-5.30-27.80-7.30-7.20-7.20-8.40-7.60-8.20
Diluted Shares Outstanding30.14M15.57M19.39M13.22M10.13M9.02M10.13M10.13M9.73M4.46M4.46M4.44M4.37M3.18M3.06M3.02M2.81M2.53M2.53M2.17M
Basic Shares Outstanding30.14M15.57M19.39M13.22M10.13M9.02M10.13M10.13M9.73M4.46M4.46M4.44M4.37M3.18M3.06M3.02M2.81M2.53M2.53M2.17M
Dividend Payout Ratio--------------------